NCT04764851 - Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 18, 2021

Primary Completion Date

April 2, 2021

Study Completion Date

May 7, 2021

Conditions

Drug-Interactions

Interventions

DRUG

ecopipam HCl ~2mg/kg/day

oral tablet

COMBINATION_PRODUCT

Cohort 1 Probe Cocktail

dextromethorphan, caffeine, omeprazole, and midazolam

COMBINATION_PRODUCT

Cohort 2 Probe Cocktail

dabigatran, pitavastatin, rosuvastatin, atorvastatin, midazolam

COMBINATION_PRODUCT

Cohort 3 Probe Cocktail

bupropion

Trial Locations (1)

Syneos Health Clinical Research Services, LLC., Miami